These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients. Huo Z, Spencer O, Miles J, Johnson J, Holliman R, Sheldon J, Riches P. Vaccine; 2004 Mar 12; 22(9-10):1157-61. PubMed ID: 15003643 [Abstract] [Full Text] [Related]
5. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. Kumar D, Rotstein C, Miyata G, Arlen D, Humar A. J Infect Dis; 2003 May 15; 187(10):1639-45. PubMed ID: 12721944 [Abstract] [Full Text] [Related]
7. Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Cherif H, Landgren O, Konradsen HB, Kalin M, Björkholm M. Vaccine; 2006 Jan 09; 24(1):75-81. PubMed ID: 16107293 [Abstract] [Full Text] [Related]
8. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Hedlund JU, Kalin ME, Ortqvist AB, Henrichsen J. Arch Intern Med; 1994 Sep 12; 154(17):1961-5. PubMed ID: 8074600 [Abstract] [Full Text] [Related]
9. Selective antibody deficiency and its relation to the IgG2 and IgG3 subclass titers in recurrent respiratory infections. Sherkat R, Shoaei P, Parvaneh N, Babak A, Kassaian N. Iran J Immunol; 2013 Mar 12; 10(1):55-60. PubMed ID: 23502339 [Abstract] [Full Text] [Related]
11. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity. Uddin S, Borrow R, Haeney MR, Moran A, Warrington R, Balmer P, Arkwright PD. Vaccine; 2006 Jul 07; 24(27-28):5637-44. PubMed ID: 16730399 [Abstract] [Full Text] [Related]
12. The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease. Gaultier GN, McCready W, Ulanova M. BMC Immunol; 2019 Nov 12; 20(1):41. PubMed ID: 31718534 [Abstract] [Full Text] [Related]
13. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases. Navarro D, Escribano A, Cebrián L, Gimeno C, García-Maset L, García-de-Lomas J, Spanish Pneumococcal Infection Study Network. Clin Vaccine Immunol; 2006 Jun 12; 13(6):665-70. PubMed ID: 16760325 [Abstract] [Full Text] [Related]
14. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. Kamchaisatian W, Wanwatsuntikul W, Sleasman JW, Tangsinmankong N. J Allergy Clin Immunol; 2006 Dec 12; 118(6):1336-41. PubMed ID: 17157665 [Abstract] [Full Text] [Related]
17. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P. Rheumatology (Oxford); 2006 Jan 12; 45(1):106-11. PubMed ID: 16287919 [Abstract] [Full Text] [Related]
18. Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report. Pasiarski M, Rolinski J, Grywalska E, Stelmach-Goldys A, Korona-Glowniak I, Gozdz S, Hus I, Malm A. PLoS One; 2014 Jan 12; 9(12):e114966. PubMed ID: 25506837 [Abstract] [Full Text] [Related]